RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS - Egyptian Knowledge Bank

222662

RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Recurrence of Hepatocellular Carcinoma in Hepatitis (C) Virus Related Cirrhosis Treated with Direct Acting Antiviral Therapy

Article

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Article

Hepatocellular Carcinoma Recurrence Post Direct-Acting Antiviral and Its Relation to Time of Treating Chronic HCV Infection

Article

HEPATOCELLULAR CARCINOMA INCIDENCE IN HEPATITIS C PATIENTS TREATED WITH DIRECT-ACTING ANTIVIRALS AND ITS RELATIONSHIP TO HEPATIC FIBROSIS STAGE

Article

Frequency of Hepatocellular Carcinoma in HCV Patients Treated with Direct-Acting Antiviral Drugs

Article

Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter s

Article

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Article

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Article

Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs)

Article

Occurrence and Recurrence of Hepatocellular Carcinoma after Direct Acting Antivirals in Compensated Chronic Hepatitis (C) Cirrhotic Egyptian Patients